These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 652070

  • 21. Hepatitis and cholestasis in a middle-aged woman.
    Perrillo RP, Mason AL, Jacob S, Gerber MA.
    Hepatology; 1996 Sep; 24(3):730-4. PubMed ID: 8781350
    [No Abstract] [Full Text] [Related]

  • 22. Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis.
    Maggiore G, Bernard O, Hadchouel M, Alagille D.
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):655-8. PubMed ID: 4032180
    [Abstract] [Full Text] [Related]

  • 23. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
    Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA.
    J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
    [Abstract] [Full Text] [Related]

  • 24. Remission of active chronic hepatitis after treatment with cyclophosphamide and prednisolone. Report of four cases.
    Pengelly CD, Jennings RC.
    Practitioner; 1975 Feb; 214(1280):233-42. PubMed ID: 1144250
    [Abstract] [Full Text] [Related]

  • 25. Treatment of chronic hepatitis.
    Mistilis SP, Lam KC.
    Prog Liver Dis; 1972 Feb; 4():419-32. PubMed ID: 4569006
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C, Carvalho P, Prost C, Verret JL, Saiag P, Noblesse I, Bedane C, Chosidow O, Young P, Roujeau JC, Joly P.
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [Abstract] [Full Text] [Related]

  • 27. [Autoimmune hepatitis: recent update on diagnosis and treatment].
    Lee YS.
    Korean J Hepatol; 2006 Sep; 12(3):318-32. PubMed ID: 16998286
    [Abstract] [Full Text] [Related]

  • 28. [Results and prognostic factors in the treatment of chronic active hepatitis with prednisone and azathioprine].
    Jorge AD, Sánchez D.
    Acta Gastroenterol Latinoam; 1985 Sep; 15(4):233-41. PubMed ID: 3842554
    [Abstract] [Full Text] [Related]

  • 29. Morphologic evolution of CAH with and without therapy. A two year follow-up.
    Celle G, Volpi C, Testa R, Dodero M.
    Hepatogastroenterology; 1980 Aug; 27(4):283-5. PubMed ID: 7203364
    [Abstract] [Full Text] [Related]

  • 30. [Follow-up of 52 patients with chronic aggressive hepatitis].
    Wyss G, Stalder GA, Bianchi L.
    Schweiz Med Wochenschr; 1977 Apr 16; 107(15):520-3. PubMed ID: 854721
    [Abstract] [Full Text] [Related]

  • 31. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease.
    Soloway RD, Summerskill WH, Baggenstoss AH, Schoenfield LJ.
    Gastroenterology; 1972 Sep 16; 63(3):458-65. PubMed ID: 4116064
    [No Abstract] [Full Text] [Related]

  • 32. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H, Fay O, Roldán L, Vorovioff J.
    Acta Gastroenterol Latinoam; 1982 Sep 16; 12(4):323-32. PubMed ID: 7185230
    [Abstract] [Full Text] [Related]

  • 33. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD, Te HS, Thomas RM, Hussain H, Bond K, Black M.
    Am J Gastroenterol; 2001 Oct 16; 96(10):2984-91. PubMed ID: 11693337
    [Abstract] [Full Text] [Related]

  • 34. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I, Said Y, Chaabouni H, Ouerghi H, Ben Ammar A.
    Ann Med Interne (Paris); 2003 Feb 16; 154(1):7-11. PubMed ID: 12746654
    [Abstract] [Full Text] [Related]

  • 35. Management of chronic aggressive hepatitis in children and adolescents.
    Arasu TS, Wyllie R, Hatch TF, Fitzgerald JF.
    J Pediatr; 1979 Oct 16; 95(4):514-22. PubMed ID: 480025
    [No Abstract] [Full Text] [Related]

  • 36. [Histological criteria for evaluation of the prognosis of chronic hepatitis].
    Oancea R, Serbănescu M, Lazăr V, Corduban T.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985 Oct 16; 37(6):511-20. PubMed ID: 2871609
    [No Abstract] [Full Text] [Related]

  • 37. Immunosuppressive therapy in chronic hepatitis in children.
    Rudkowski Z, Rabenda C.
    Mater Med Pol; 1974 Oct 16; 6(3):202-6. PubMed ID: 4444336
    [No Abstract] [Full Text] [Related]

  • 38. [Prednisone and imuran in the treatment of polyarteritis nodosa].
    Bednorz W, Checińska Z, Głebowska H, Medraś M, Plamieniak Z, Zareba-Bogdał E.
    Wiad Lek; 1978 Aug 15; 31(16):1153-8. PubMed ID: 30213
    [No Abstract] [Full Text] [Related]

  • 39. [Comparative studies on the effect of delayed therapy of chronic inflammatory liver diseases with prednisone or immunosuppressive agents].
    Evers C, Vorpahl WD, Weinreich J.
    Med Welt; 1971 Mar 20; 12():465-8. PubMed ID: 5560083
    [No Abstract] [Full Text] [Related]

  • 40. [Therapy of chronic hepatitis (author's transl)].
    Auer IO.
    Leber Magen Darm; 1980 Oct 20; 10(5):251-8. PubMed ID: 6162069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.